← Back to search

Cellbyte

AI Agents for Pharma Drug Launches

Y CombinatorWinter 2022ActiveHealthcareHealthcare ITData ScienceHealthcare ITAI

What they do

Problem

Pharma companies struggle to quickly and accurately determine optimal pricing and launch strategies for new drugs across different global markets.

Solution

Cellbyte provides AI agents that answer commercialization questions and support worldwide drug launches, including market-by-market pricing guidance.

Who it's for

Pharmaceutical companies and life sciences teams responsible for global drug commercialization and launch planning.

Founders

Felix Steinbrenner
Co-Founder & CEO

Co-founder & CEO of Cellbyte. We are building AI agents to accelerate the launch and commercialization of pharmaceutical drugs. Pivoted from Last Mile Logistics in 2023: previously co-founded and led Operations at Glocally (W22), where we offered a same-day parcel delivery service to e-commerce brands like H&M. Utilizing electric vehicles only, we surpassed 150K parcels with excellent reviews, and raised >$2M from top-tier Angels and VCs (YC, Trucks,...).

Company timeline

Similar startups